Roivant Sciences Ltd.(ROIV),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ROIV Roivant Sciences Ltd.

Closed Juneteenth National Independence Day 06-18 16:00:00 EDT

31.43

+0.23

+0.74%

盘后31.00

-0.43-1.37%

19:35 EDT

High32.11	Low30.57	Vol8.26M
Open31.74	D1 Closing31.20	Amplitude4.94%
Mkt Cap22.49B	Tradable Cap14.68B	Total Shares715.70M
T/O258.69M	T/O Rate1.77%	Tradable Shares467.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ROIV","market":"US","secType":"STK","nameCN":"Roivant Sciences Ltd.","latestPrice":31.43,"timestamp":1781812800000,"preClose":31.2,"halted":0,"volume":8263245,"hourTrading":{"tag":"盘后","latestPrice":31,"preClose":31.43,"latestTime":"19:35 EDT","volume":1070358,"amount":33641208.4443,"timestamp":1781825747032,"change":-0.43,"changeRate":-0.013681,"amplitude":0.013681},"delay":0,"changeRate":0.0073717948717948855,"floatShares":467000000,"shares":715701137,"eps":-0.539999,"marketStatus":"Closed Juneteenth National Independence Day","change":0.23,"latestTime":"06-18 16:00:00 EDT","open":31.74,"high":32.11,"low":30.57,"amount":258690015.610725,"amplitude":0.049359,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.539999,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1782115200000},"marketStatusCode":7,"adr":0,"listingDate":1607403600000,"exchange":"NASDAQ","adjPreClose":31.2,"preHourTrading":{"tag":"盘前","latestPrice":31.82,"preClose":31.2,"latestTime":"09:29 EDT","volume":4307,"amount":136325.323359,"timestamp":1781789399999,"change":0.62,"changeRate":0.019872,"amplitude":0.014103},"postHourTrading":{"tag":"盘后","latestPrice":31,"preClose":31.43,"latestTime":"19:35 EDT","volume":1070358,"amount":33641208.4443,"timestamp":1781825747032,"change":-0.43,"changeRate":-0.013681,"amplitude":0.013681},"volumeRatio":1.6175800584425721,"impliedVol":0.3296,"impliedVolPercentile":0.3426},"requestUrl":"/m/hq/s/ROIV","defaultTab":"news","newsList":[{"id":"2644767441","title":"Immunovant director Atul Pande disposes of USD 51,030 common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2644767441","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644767441?lang=en_us&edition=fundamental","pubTime":"2026-06-17 04:03","pubTimestamp":1781640228,"startTime":"0","endTime":"0","summary":"Immunovant director Atul Pande sold 1,500 shares on June 15, 2026 at USD 34.02.He also acquired 1,500 shares the same day via option exercise at USD 8.43.Derivative holdings included 69,681 stock options following the transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunovant Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 16, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDL6VlcnR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ROIV","BK4588","BK4007","BK4585","IMVT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643975945","title":"Piper Sandler Sticks to Their Buy Rating for Roivant Sciences (ROIV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2643975945","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643975945?lang=en_us&edition=fundamental","pubTime":"2026-06-16 19:00","pubTimestamp":1781607627,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Roivant Sciences today and set a price target of $40.00. According to TipRanks, Rah...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-their-buy-rating-for-roivant-sciences-roiv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-sticks-to-their-buy-rating-for-roivant-sciences-roiv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ROIV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639260672","title":"Immunovant director Andrew J. Fromkin reports common share disposal worth $7.44 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2639260672","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639260672?lang=en_us&edition=fundamental","pubTime":"2026-05-30 04:05","pubTimestamp":1780085153,"startTime":"0","endTime":"0","summary":"Immunovant director Andrew J. Fromkin sold 221,951 shares on May 28, 2026 at weighted-average prices of $32.64 and $33.56.He exercised stock options for 196,601 shares the same day at exercise prices ranging from $4.99 to $14.7.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunovant Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 29, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL1j1p0m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMVT","BK4139","BK4007","ROIV","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638517649","title":"Roivant Sciences Is Maintained at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2638517649","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638517649?lang=en_us&edition=fundamental","pubTime":"2026-05-26 21:07","pubTimestamp":1779800820,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ROIV/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 26, 2026 09:07 ET (13:07 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","ROIV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638161785","title":"Analysts Offer Insights on Healthcare Companies: Roivant Sciences (ROIV), Crescent Biopharma (CBIO) and Genmab (GMAB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2638161785","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638161785?lang=en_us&edition=fundamental","pubTime":"2026-05-26 19:00","pubTimestamp":1779793250,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Roivant Sciences (ROIV), Crescent Biopharma (CBIO) a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-roivant-sciences-roiv-crescent-biopharma-cbio-and-genmab-gmab-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-roivant-sciences-roiv-crescent-biopharma-cbio-and-genmab-gmab-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GMAB","HCSG","BK4585","BK4139","LU0128526141.USD","XLV","BK4588","LABU","LU0029874061.USD","ROIV","BK4137","BK4007","XBI","CBIO","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638393735","title":"Roivant Sciences price target raised to $31.50 from $29.50 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2638393735","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638393735?lang=en_us&edition=fundamental","pubTime":"2026-05-25 17:00","pubTimestamp":1779699655,"startTime":"0","endTime":"0","summary":"BofA analyst Chi Fong raised the firm’s price target on Roivant Sciences (ROIV) to $31.50 from $29.50 and keeps a Neutral rating on the shares. The...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/roivant-sciences-price-target-raised-to-31-50-from-29-50-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/roivant-sciences-price-target-raised-to-31-50-from-29-50-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ROIV","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637347691","title":"Roivant President, Immunovant CEO Eric Venker disposes common shares worth $7.23 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2637347691","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637347691?lang=en_us&edition=fundamental","pubTime":"2026-05-23 06:26","pubTimestamp":1779488781,"startTime":"0","endTime":"0","summary":"Roivant President and Immunovant CEO Eric Venker reported the sale of 200,000 common shares on May 22 at a weighted average price of $30.27.He also exercised stock options for 200,000 common shares on May 22 at $3.85.Venker disposed of 34,483 common shares on May 20 at $32.41.He held 1,613,063 common shares following the transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Roivant Sciences Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 22, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nNDL8bLkBQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMVT","BK4588","BK4139","ROIV","BK4585","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637311253","title":"Should Roivant’s One‑Off Driven Profitability Shift Require Action From Roivant Sciences (ROIV) Investors?","url":"https://stock-news.laohu8.com/highlight/detail?id=2637311253","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637311253?lang=en_us&edition=fundamental","pubTime":"2026-05-22 19:36","pubTimestamp":1779449773,"startTime":"0","endTime":"0","summary":"Roivant Sciences reported past fourth-quarter 2026 results showing sales of US$2.52 million versus US$7.57 million a year earlier, with net income of US$302.99 million replacing a net loss of US$206.48 million.\nThis sharp quarterly swing to profitability came despite full-year sales falling to US$8.26 million from US$29.05 million, highlighting the impact of one-off items and cost or portfolio shifts on the bottom line.\nNext, we will examine how Roivant’s unexpected quarterly profitability...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-roiv/roivant-sciences/news/should-roivants-oneoff-driven-profitability-shift-require-ac","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-roiv/roivant-sciences/news/should-roivants-oneoff-driven-profitability-shift-require-ac","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","BK4007","ISBC","BK4211","ROIV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637380281","title":"Roivant Sciences Price Target Maintained With a $34.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2637380281","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637380281?lang=en_us&edition=fundamental","pubTime":"2026-05-21 19:10","pubTimestamp":1779361800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ROIV/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 21, 2026 07:10 ET (11:10 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","ROIV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637382584","title":"Analysts Offer Insights on Healthcare Companies: Incyte (INCY), Kindly MD (NAKA) and Roivant Sciences (ROIV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2637382584","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637382584?lang=en_us&edition=fundamental","pubTime":"2026-05-21 18:20","pubTimestamp":1779358807,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Incyte (INCY), Kindly MD (NAKA) and Roivant Sciences...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-incyte-incy-kindly-md-naka-and-roivant-sciences-roiv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-incyte-incy-kindly-md-naka-and-roivant-sciences-roiv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","XLV","BK4137","HCSG","INCY","LABU","BK4585","BK4139","ROIV","LU0128526141.USD","XBI","MD","BK4532","NAKA","BK4550","LU0029874061.USD","BK4581","BK4007","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637686384","title":"Roivant Sciences Ltd : Leerink Partners Raises Target Price to $42 From $38","url":"https://stock-news.laohu8.com/highlight/detail?id=2637686384","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637686384?lang=en_us&edition=fundamental","pubTime":"2026-05-21 18:05","pubTimestamp":1779357912,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nFWN41Y09H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4007","ROIV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637877037","title":"Immunovant director Atul Pande disposes 6,000 shares for $192,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2637877037","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637877037?lang=en_us&edition=fundamental","pubTime":"2026-05-21 09:22","pubTimestamp":1779326554,"startTime":"0","endTime":"0","summary":"Immunovant director Atul Pande reported selling 6,000 common shares at USD 32 on May 20, 2026.The sale followed the exercise of 6,000 stock options at USD 8.43 per share on the same day.Pande’s direct common share holdings fell to 116,731 shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunovant Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 20, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDLbXDHhV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","IMVT","BK4588","ROIV","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637824236","title":"BUZZ-U.S. STOCKS ON THE MOVE-Nvidia, Hasbro, Micron","url":"https://stock-news.laohu8.com/highlight/detail?id=2637824236","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637824236?lang=en_us&edition=fundamental","pubTime":"2026-05-21 01:41","pubTimestamp":1779298900,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Nvidia, Hasbro, MicronWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https:/","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nL6N41X0QX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDLN","PLUL","FANG","AVGO","2NVD.UK","WDC","TGT","TJX","WDCX","DVN","TOL","LCLN","KEYS","CVS","PLUG","VFC","MEC","RAL","HAL","ADI","AMC","RCL","CHRW","XOM","XOMO","HAS","APA","3NVD.UK","ROIV","SNDK","CAVA","XOMZ","EOG","NEM","NVIW.SI","ELV","SNXX","OXY","NVDA","CVX","HUM","SITM","XOMX","VIAV","MU","RBLX","CNC","AKAM","LOW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104990985","title":"Stock Track | Roivant Sciences Soars 15.99% Intraday on Unexpected Q4 Profit and Promising Arthritis Drug Data","url":"https://stock-news.laohu8.com/highlight/detail?id=1104990985","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104990985?lang=en_us&edition=fundamental","pubTime":"2026-05-21 01:04","pubTimestamp":1779296697,"startTime":"0","endTime":"0","summary":"Shares of Roivant Sciences Ltd. (ROIV) surged 15.99% during intraday trading on Wednesday, following the release of its fourth-quarter financial results and positive updates on its clinical...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ROIV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637821370","title":"Roivant Sciences rises 15.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637821370","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637821370?lang=en_us&edition=fundamental","pubTime":"2026-05-21 00:05","pubTimestamp":1779293153,"startTime":"0","endTime":"0","summary":"Roivant Sciences (ROIV) is up 15.2%, or $4.28 to $32.49. Published first on TheFly – the ultimate source for real-time, market-moving breaking fina...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/roivant-sciences-rises-15-2-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/roivant-sciences-rises-15-2-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4007","ROIV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636282933","title":"BUZZ-U.S. STOCKS ON THE MOVE-Royal Caribbean Cruises, AMC Entertainment, Roivant","url":"https://stock-news.laohu8.com/highlight/detail?id=2636282933","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636282933?lang=en_us&edition=fundamental","pubTime":"2026-05-20 23:42","pubTimestamp":1779291763,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Royal Caribbean Cruises, AMC Entertainment, RoivantWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nL6N41X13T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2750360641.GBP","LU0053666078.USD","NVIW.SI","SG9999015986.USD","LU0256863902.USD","IE00BKDWB100.SGD","LU2417539215.USD","LU2092937148.SGD","BK4549","GB00BDT5M118.USD","LU0882574055.USD","LU1623119135.USD","LU2347655073.USD","LU0300736492.USD","BK4534","BK4565","LU0965508806.USD","LU2237443895.HKD","IE0034235188.USD","LU0289961442.SGD","BK4096","LU0048573561.USD","IE00BJJMRX11.SGD","IE00BMCWC346.EUR","LU0823421333.USD","LU1223082519.USD","BK4597","LU1037948541.HKD","LU0187121727.USD","LU2462157665.USD","LU2247934214.USD","LU2237443622.USD","LU0476273544.USD","LU0353189763.USD","LU0444971666.USD","LU0957791311.USD","LU2764263203.CNY","SG9999014914.USD","LU1267930227.SGD","LU0203347892.USD","LU0133085943.USD","IE00B19Z3581.USD","LU0266512473.USD","LU2028103732.USD","IE0009G5SDU7.USD","IE00BK4W5L77.USD","IE0034235295.USD","LU0143551892.USD","LU0306807586.USD","LU2249611893.SGD","LU2065170008.USD","BK4559","LU0075056555.USD","SG9999014898.SGD","LU0795875169.SGD","LU0130103400.USD","LU1069344957.HKD","LU0124676726.USD","LU0345770993.USD","BK4116","LU1066051225.USD","NVDS.UK","SG9999014005.SGD","LU1815336091.USD","LU0107464264.USD","LU2430703251.USD","LU2471134523.USD","LU0170899867.USD","LU0654597011.USD","LU2168564065.EUR","LU2279689827.SGD","LU2092627202.USD","IE00B3SWFQ91.USD","IE00BN29S564.USD","LU2860962120.EUR","BK4209","BK4020","LU0784383803.USD","NVD2.UK","LU1582986433.USD","LU0456854461.SGD","LU1582986359.USD","LU2089284900.SGD","BK4585","AVL","LU1894683264.USD","IE00BDRTCR15.USD","LU0949170426.SGD","LU0345768153.USD","LU0348723411.USD","LU2420271590.USD","LU0390134368.USD","LU0708994859.HKD","LU1093756168.USD","LU0786609619.USD","LU2125909247.SGD","LU0943347566.SGD","LU0234572021.USD","LU2237443549.SGD","LU0289739699.SGD","LU2322448791.USD","AVS","LU0128525929.USD","LU0788109477.HKD","IE0004445239.USD","AVGU","IE0002270589.USD","NWMX","HK0000304805.HKD","LU1267930573.SGD","IE00BGHQDM52.EUR","LU0061474960.USD","LU1861127337.USD","LU2242650005.HKD","LU1894683348.USD","BK4516","IE00BHPRN162.USD","IE000W1ABFV2.USD","LU0321505439.SGD","LU0082616367.USD","LU2236285917.USD","HK0000320264.USD","LU1400636657.SGD","LU2087621335.USD","IE00BVYPNQ40.USD","LU1868837136.USD","LU2637965513.SGD","SG9999014567.USD","LU1093756325.SGD","LU1582987324.SGD","LU1861215975.USD","LU0276348264.USD","LU0130518102.USD","LU0820562030.AUD","LU1861559042.SGD","LU2360032135.SGD","NVDU","LU1400636574.HKD","SG9999015945.SGD","LU0225771236.USD","LU1720051017.SGD","LU0949170772.SGD","BK4088","LU2413666426.HKD","LU2362541273.HKD","LU1670756490.USD","LU2237957902.USD","LU0068578508.USD","LU0251132253.USD","SG9999014880.SGD","AVGG","LU0320765646.SGD","LU0130517989.USD","LU0274383776.USD","LU2125154778.USD","LU0345780521.USD","LU2471134952.CNY","LU0096364046.USD","LU0683600562.USD","LU0784384876.USD","LU1989764748.USD","LU1929549753.HKD","BK4515","NVDQ","LU2237443465.HKD","LU0061474705.USD","PLUL","LU0203201768.USD","LU0345770308.USD","BK4579","LU1430597077.USD","LU2506951875.HKD","LU1983260115.SGD","LU0957808578.USD","NVDY","LU2065171402.SGD","LU0321505868.SGD","HK0000914660.USD","LU2097344357.USD","IE00BJLML261.HKD","LU2092937221.SGD","LU0158827781.USD","BK4575","LU1914381329.SGD","NVDG","LU0368265418.SGD","LU0057025933.USD","LU1244550494.USD","LU0124384867.USD","LU1035775433.USD","LU1571399168.USD","LU1868836757.USD","LU2106854487.HKD","LU1585245621.USD","LU0784385840.USD","BK4581","LU0072461881.USD","SG9999015978.USD","LU0203345920.USD","LU2237443978.SGD","LU1804176565.USD","NVDS","LU0070217475.USD","LU0314106906.USD","IE00B19Z8X17.USD","LU0640476718.USD","LU0320765489.SGD","AVGX","BK4131","LU0494093205.USD","LU2125909916.SGD","LU0498741890.SGD","BK4503","SG9999018865.SGD","BK4535","LU1223082196.USD","BK4541","IE00B3PB1722.GBP","LU1670710588.SGD","BK4142","LU1935043536.SGD","LU0210533765.USD","LU2357627491.SGD","LU0417517546.SGD","IE0034235303.USD","BK4083","LU0738911758.USD","BK4548","IE00B4YYXB79.USD","LU2168564222.USD","LU1429558221.USD","LU1852331112.SGD","LU2999663052.SGD","SNDU","LU1291159041.SGD","SG9999001077.SGD","LU0553294199.USD","LU1923623000.USD","XOMZ","LU1153585028.USD","LU0823417653.USD","RBLY","SGXZ99366536.SGD","BK4587","LU0820561818.USD","LU1261432733.SGD","BK4094","LU0979878070.USD","IE00BJTD4V19.USD","IE00B4JS1V06.HKD","LU1023059493.AUD","BK4543","LU1150488218.USD","LU1814569148.SGD","LU0127658192.USD","LU0128525689.USD","IE00B7SZLL34.SGD","BK4533","IE00BFXG1179.USD","LU1127390331.HKD","BK4588","07388","LU1935042991.SGD","LU2505996509.AUD","LU0330918003.SGD","LU2244417387.USD","LU2290526834.HKD","IE00B19Z9P08.USD","IE00BWXC8680.SGD","LU0061475181.USD","LU1951200564.SGD","LU0868494617.USD","LU1506573853.SGD","LU0006306889.USD","LU0950375773.USD","LU1934455277.USD","BK4602","BK4529","LU1084165304.USD","LU0052756011.USD","LU0823414478.USD","LU0859254822.USD","LU1119994496.HKD","LU2746668974.SGD","LU0208291251.USD","IE00B1BXHZ80.USD","SGXZ51526630.SGD","LU0316494557.USD","IE00BYV24P56.USD","LU2491049909.HKD","LU2129689514.USD","LU1323610961.USD","SGXZ31699556.SGD","IE00B775H168.HKD","BK4155","LU2471134796.USD","IE00BJTD4N35.SGD","BK4598","BK4141","LU1116320737.USD","LU0215105999.USD","SG9999002521.SGD","LU2264538146.SGD","LU2355687059.USD","LU2322448957.HKD","LU0433182093.SGD","LU0203202063.USD","LU2552382132.HKD","LU0511384066.AUD","LU1923622614.USD","BK4161","LU0154236417.USD","LU2041044095.USD","LU1989764664.SGD","LU2065169927.USD","LU1718418525.SGD","LU2133065610.SGD","LU2491050154.USD","LU0912757837.SGD","LU0444973449.USD","LU0642271901.SGD","BK4563","BK4532","LU2458330169.SGD","LU2111349929.HKD","IE00B775SV38.USD","LU0011850046.USD","BK4170","LU0077335932.USD","LU0965509010.AUD","LU1823568750.SGD","SGXZ81514606.USD","BK4201","IE00BQXX3D17.EUR","LU1815333072.USD","LU0210528500.USD","2NVD.UK","LU0198837287.USD","LU2237443382.USD","BK4614","LU0058720904.USD","LU1242518931.SGD","LU1366333091.USD","LU2098885051.SGD","LU1978683503.SGD","ANV","IE00BDCRKT87.USD","LU0320765059.SGD","LU0861579265.USD","LU1642822529.SGD","NVII","IE00BJJMRY28.SGD","IE00BMPRXR70.SGD","LU0980610538.SGD","LU2506951958.HKD","IE000KEQY171.SGD","LU1691799644.USD","LU0266512127.USD","LU1064131342.USD","LU2168563687.JPY","LU0251142724.SGD","LU2487616109.SGD","LU2756315664.SGD","WDCX","IE00B5TLWC47.USD","LU0889565833.HKD","SG9999001143.SGD","LU2213496289.HKD","IE00BBT3K403.USD","LU1720051108.HKD","LU2458330243.SGD","HK0000914686.HKD","LU1244550221.USD","XOMO","LU2265009873.SGD","LU0158827948.USD","LU1267930730.SGD","LU2360107325.USD","IE00BQXX3F31.USD","LU0964807845.USD","LU1301847155.USD","HK0000306701.USD","LU0868494708.USD","IE00BVYPNW00.USD","LU1992135472.HKD","LU0006061336.USD","LU1935042488.USD","LU1057294990.SGD","LU0965509101.SGD","LU2298321311.HKD","LU2361044865.SGD","BK4017","LU0345768740.USD","LU2506951792.HKD","IE00BLSP4239.USD","LU0055631609.USD","BK4007","IE000ITXATA3.USD","LU0267386448.USD","LU1721428933.USD","07788","LU1974910355.USD","LU1821325948.USD","LU2294711713.HKD","BK4114","LU0157215616.USD","LU0205194284.USD","IE0004091025.USD","LU0079474960.USD","LU2552382215.SGD","SG9999004303.SGD","LU1989772923.USD","SG9999001424.SGD","LU1551013425.SGD","LU2023251221.USD","HK0000320223.HKD","IE0001KFT4U8.USD","LU0724618433.USD","IE00B3S45H60.SGD","LU0081259029.USD","LU2210149790.SGD","LU0306806265.USD","LU0225283273.USD","LU0354030511.USD","LU0726765562.USD","BK4605","LU0792757196.USD","LU0432979614.USD","LU2506952097.USD","LU0724617625.USD","BK4085","NVDW","LU0787776722.HKD","LU0353189680.USD","LU0985489474.SGD","LU0289739343.SGD","BK4566","SG9999014559.SGD","LU2360107168.USD","LU1035773651.USD","LU0719512351.SGD","LU0557290698.USD","LU2347655156.SGD","LU2129689431.USD","IE00BN0W2T93.GBP","LU0345780281.USD","SG9999011175.SGD","IE00BD6J9T35.USD","BK4550","LU0648000940.SGD","IE000YTNTUN2.SGD","LU2764262908.HKD","LU1059921491.USD","IE00BZ9MQY76.HKD","LU0256863811.USD","BK4612","LU0823421416.USD","LU0345769631.USD","LU0612318971.USD","LU0122376428.USD","SG9999014013.SGD","LU0466842654.USD","IE00BFSS7M15.SGD","LU1400636491.USD","IE00B42XCP33.USD","RCL","LU0302445910.USD","LU2023250504.SGD","LU1935042215.USD","NVDO","LU0823434583.USD","LU2102340556.USD","SG9999002232.USD","IE00B894F039.SGD","LU0225284248.USD","SGXZ23171101.USD","LU0788109394.HKD","LU0308772762.SGD","LU1670711123.USD","LU1003077747.HKD","IE00BQXX3C00.GBP","LU2089985449.USD","LU0368265764.SGD","LU1674673428.USD","BK4561","LU0238689110.USD","BK4154","IE00BMPRXN33.USD","LU0496367417.USD","SNVD.UK","LU1878469433.USD","LU1670710661.SGD","LU1069347547.HKD","LU2360106780.USD","IE00B7KXQ091.USD","IE00BVYPNP33.GBP","HK0000532082.HKD","LU1868837300.USD","LU0963586101.USD","LU0354030438.USD","BK4608","LU2543165471.USD","LU2357305700.SGD","BK4592","LU0757428866.USD","LU0094547139.USD","LU1267930813.SGD","LU0109391861.USD","BK4198","LU0211331839.USD","LU1815336760.USD","XOMX","IE00BYXW3230.USD","LU2360108059.USD","LU1242518857.USD","LU2461242641.AUD","LU2394011477.USD","LU0175139822.USD","SG9999015341.SGD","LU0174119429.USD","LU2430703178.SGD","BK4504","LU1732799900.SGD","LU1037948897.HKD","LU0130102774.USD","LU0942090050.USD","LU1435385759.SGD","LU1670711040.USD","LU1917777945.USD","LU0210536198.USD","LU0029864427.USD","LU1989771016.USD","LU1883866441.USD","LU1791710582.SGD","IE00BVYPNV92.GBP","LU0098860793.USD","BK4139","LU1169590202.USD","NVDB","LU1202635105.USD","LU0528227936.USD","LU1989772840.SGD","LU2125909759.SGD","LU1169589451.USD","SG9999014575.USD","LU2125909593.SGD","LU0342679015.USD","LU0823411888.USD","LU2362541513.USD","LU2211814178.USD","LU0048584097.USD","BK4517","SG9999015952.SGD","LU0689472784.USD","LU1582987597.SGD","3NVD.UK","NVD3.UK","LU1935043023.USD","LU0149725797.USD","NVDX","LU2271345857.HKD","LU1988902786.USD","AVGW","LU0630314457.HKD","LU0240877869.USD","LU0234570918.USD","LU1923622291.USD","LU2506952170.USD","LU0256331488.USD","LU0823417737.USD","LU1489326972.SGD","LU0096362180.USD","SG9999003800.SGD","LU0498741114.HKD","LU0648001328.SGD","LU0724618789.USD","LU1645745479.HKD","LU1674673691.USD","LU0795875086.SGD","LU2720916845.USD","LU2063271972.USD","LU2298322129.HKD","LU2129689605.HKD","BK4157","IE00BSNM7G36.USD","LU2473716301.USD","LU2077746001.SGD","BK4551","IE00BLSP4452.SGD","LU0742534661.SGD","LU1670627923.USD","BK4512","LU0477156797.USD","LU1732800096.USD","LU2471134879.HKD","LU2746668461.USD","LU2083900584.USD","LU0689626769.HKD","BK4202","LU0820561909.HKD","IE00B19Z8W00.USD","LU2357125470.USD","LU1303367103.USD","NVD","LU1951198990.SGD","LU1934455194.USD","LU0985481810.HKD","LU2250418816.HKD","LU2896262040.SGD","IE0003U64NQ7.SGD","LU0054578231.USD","LU0072462426.USD","LU0545039389.USD","BK4527","LU2089283258.USD","LU0823414551.USD","LU2462611646.USD","LU1983299246.USD","LU0661504455.SGD","LU1366192091.USD","CNCG","LU1868836914.USD","LU0823434740.USD","LU0106261372.USD","SG9999002224.SGD","LU1861214812.USD","LU0672654240.SGD","LU1934455863.HKD","LU2462591350.SGD","LU2191332357.HKD","IE00B3M56506.USD","LU0323591593.USD","LU0878866978.SGD","BK4554","IE0004086264.USD","LU0278409577.USD","BK4213","LU1074936037.SGD","LU2237438978.USD","LU2362540622.SGD","NVDL","LU0080751232.USD","LU0345781412.USD","LU0310800379.SGD","LU2954938101.SGD","IE0004445015.USD","LU0122379950.USD","LU1712237335.SGD","LU2237957811.SGD","LU2168564149.EUR","LU0251131958.USD","LU1280957306.USD","SG9999017495.SGD","LU1496350171.SGD","LU1023059063.AUD","LU0265550946.USD","LU2764263039.SGD","SG9999001440.SGD","LU1046421795.USD","LU2023250330.USD","LU0205193047.USD","LU1223083913.SGD","BK4196","LU1496350502.SGD","LU1861219969.SGD","LU2168564495.EUR","NVYY","IE00B1XK9C88.USD","IE00B3CCJ963.GBP","LU1861558580.USD","HK0000819398.USD","LU1150488135.SGD","LU1629891620.HKD","ROIV","HK0000304797.USD","LU2097344431.USD","LU0314104364.USD","LU1551013342.USD","IE00BKVL7J92.USD","LU1201861165.SGD","LU0882574139.USD","LU2552382058.USD","LU0708995401.HKD","LU2602419157.SGD","LU1116320901.HKD","IE00B2Q91V27.USD","LU1803068979.SGD","LU0070302665.USD","LU1868836591.USD","LU2047632596.USD","LU2361044949.HKD","BK4570","IE00BZ1G4Q59.USD","LU0211328371.USD","LU2211815571.USD","LU2498475776.HKD","LU2462591277.SGD","LU1235294995.USD","IE00BMPRXQ63.HKD","SG9999018857.SGD","LU1670628061.USD","LU0965509283.SGD","LU2272731782.SGD","AMC","BK4108","IE00BGHQF631.EUR","LU0784385170.HKD","SG9999000418.SGD","IE00BGHQF524.EUR","LU2413666699.HKD","IE00B5949003.HKD","LU0312595415.SGD","LU0240878834.USD","LU0788109121.HKD","LU2054465674.USD","LU2272731865.HKD","LU1839511570.USD","LU1244550577.SGD","LU1066053197.SGD","LU1066051811.HKD","LU2931357623.SGD","LU2087625088.SGD","LU2491050071.SGD","IE00BKPKM429.USD","LU1145028129.USD","LU2286300806.USD","LU2108987350.USD","IE00BN8TJ469.HKD","LU0472753341.HKD","LU1267930490.SGD","LU2275660780.HKD","LU1791710400.SGD","IE00B19Z3B42.SGD","LU0300736062.USD","HK0000306685.HKD","IE00B19Z9Z06.USD","LU0097036916.USD","LU0889566641.SGD","LU0985320562.USD","LU2592432038.USD","LU2100268510.USD","LU2242649171.HKD","IE00BDGV0183.EUR","BK4547","LU0612318385.USD","LU0788108826.HKD","LU2433249047.HKD","LU2403377893.USD","LU2095319765.USD","RBLU","SG9999015358.SGD","LU0211327993.USD","LU1232071149.USD","LU2381873111.SGD","LU0310800965.SGD","LU2272731600.USD","LU2505996681.GBP","LU0345769128.USD","LU1066051498.USD","LU0289960550.SGD","SNXX","LU2361045086.USD","IE00BZ199S13.USD","LU0162691827.USD","LU1201861249.SGD","LU0265550359.USD","LU2750360997.AUD","LU2456880835.USD","SG9999014021.USD","LU1162221912.USD","NEMG","IE00BFSS8Q28.SGD","LU1316542783.SGD","LU2210150020.SGD","NVDD","LU2756315318.SGD","SG9999014542.SGD","LU2463028550.USD","LU1633808545.USD","LU0069063385.USD","LU1861220033.SGD","IE000M9KFDE8.USD","LU1992135399.USD","IE00B19Z9505.USD","LU0266013472.USD","LU0109392836.USD","LU1778281490.HKD","LU2452424414.USD","LU2326559502.SGD","LU0310799852.SGD","LU0477156953.USD","LU2065171311.SGD","LU1559883803.SGD","LU2023250843.SGD","LU2430703095.HKD","SG9999014906.USD","LU0056508442.USD","IE00BN0W2V16.EUR","LU0566484027.USD","IE00BN0W2W23.USD","LU1430594728.SGD","LU0114720955.EUR","IE00BK4W5M84.HKD","IE0009356076.USD","LU3102509885.SGD","LU0345780950.USD","DIPS","BK4596","LU0347712357.USD","LU1699723380.USD","LU1803068623.USD","LU1548497426.USD","LU2125154935.USD","BK4179","IE0005OL40V9.USD","BK4567"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636829834","title":"2 Biotech Stocks Are Surging Today Thanks to This Arthritis Drug -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2636829834","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636829834?lang=en_us&edition=fundamental","pubTime":"2026-05-20 23:38","pubTimestamp":1779291480,"startTime":"0","endTime":"0","summary":"A clinical breakthrough trumped fiscal pain for Roivant Sciences and its subsidiary Immunovant on Wednesday as investors traded weak quarterly results for compelling study data.For Roivant's March quarter, revenue came in at $2.52, short of Wall Street's $3.56 million consensus. Immunovant's earnings told a similar story: The company posted a loss of $147.9 million, or 73 cents a share, in its latest quarter. Analysts had anticipated a per-share loss of 59 cents.IMVT-1402 belongs to a class of targeted therapeutics that includes approved drugs from Johnson & Johnson and Dutch biotech Argenx. Although the class could yield up to $78 billion in peak annual sales over time, \"this potential is not reflected in market expectations,\" Goldman Sachs analyst Corinne Johnson wrote last month.The latest data were \"highly compelling,\" Risinger wrote. In his view, IMVT-1402 could corner the market for D2T RA, given the drug's \"differentiated mechanism and compelling efficacy in people who have fail","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"3a8b9766ee9af93acdd4c2a16a2c1acc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0109394709.USD","LU1983260115.SGD","IE00BJT1NW94.SGD","IMVT","XBI","BK4588","IE0034235188.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","ROIV","BK4139","LU0889565916.HKD","BK4505","ARGX","IE00B2B36J28.USD","IE0002141913.USD","LU2324357040.USD","IE0009355771.USD","LU0320765992.SGD","BK4007","IE00BJJMRZ35.SGD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636253178","title":"BUZZ-Roivant rises as arthritis drug shows early promise","url":"https://stock-news.laohu8.com/highlight/detail?id=2636253178","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636253178?lang=en_us&edition=fundamental","pubTime":"2026-05-20 22:37","pubTimestamp":1779287823,"startTime":"0","endTime":"0","summary":"BUZZ-Roivant rises as arthritis drug shows early promise** Shares of drug developer Roivant Sciences ROIV.O rise 14.3% to $32.23 ** Co says early-stage data showed its experimental drug,  IMVT-1402, reduced symptoms in patients with difficult-to-treat rheumatoid arthritis , an autoimmune condition that causes joint pain and swelling** Says among 165 evaluable patients, 72.7% of patients showed a ≥ 20% improvement from baseline in tender joint count and swollen joint count, while 54.5% and 35.8% showed higher responses ** Cantor Fitzgerald says the responses \"are meaningfully better than any benchmark in this highly refractory rheumatoid arthritis setting\" ** Leerink Partners says \"We thus see the potential for IMVT-1402 to become a blockbuster in D2T RA given its differentiated mechanism and compelling efficacy in patients who have failed multiple prior therapies\" ** ROIV expects to provide further updates on the program in the second half of 2026 ** Including session's move, ROIV up 4","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nL4N41X1D5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ROIV","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193213945","title":"Movement Alert｜Roivant Sciences Rises 11.1% in Regular Trading, Business Progress Updates Drive Positive Market Reaction Despite Revenue Miss","url":"https://stock-news.laohu8.com/highlight/detail?id=1193213945","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193213945?lang=en_us&edition=fundamental","pubTime":"2026-05-20 21:40","pubTimestamp":1779284441,"startTime":"0","endTime":"0","summary":"On May 20, Roivant Sciences rose 11.1% in regular trading, trading at $30.54/share, with trading volume of approximately $35.74 million. The rally was driven by the company's disclosure of fiscal...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ROIV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636840052","title":"Roivant Sciences Ltd reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2636840052","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636840052?lang=en_us&edition=fundamental","pubTime":"2026-05-20 21:31","pubTimestamp":1779283912,"startTime":"0","endTime":"0","summary":"Roivant Sciences Ltd reports results for the quarter ended March 31 - Earnings SummaryRoivant Sciences Ltd ROIV.OQ reported a quarterly adjusted loss of 58 cents per share for the quarter ended March ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nL8N41X1CT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ROIV","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://roivant.com;investor.roivant.com","stockEarnings":[{"period":"1week","weight":0.0572},{"period":"1month","weight":0.1141},{"period":"3month","weight":0.1347},{"period":"6month","weight":0.4025},{"period":"1year","weight":1.7474},{"period":"ytd","weight":0.4484}],"compareEarnings":[{"period":"1week","weight":0.0122},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.1514},{"period":"6month","weight":0.0972},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.0951}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Roivant Sciences Ltd., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammation and immunology areas. The company provides Vants, a model to develop and commercialize its medicines and technologies focusing on biopharmaceutical businesses, discovery-stage companies, and health technology startups. It develops VTAMA, a novel topical for the treatment of psoriasis and atopic dermatitis; batoclimab and IMVT-1402, the fully human monoclonal antibodies targeting the neonatal Fc receptor across various IgG-mediated autoimmune indications; and RVT-3101, an anti-TL1A antibody for ulcerative colitis and Crohn's disease. The company was founded in 2014 and is based in London, the United Kingdom.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.071559},{"month":2,"riseRate":0.333333,"avgChangeRate":0.052607},{"month":3,"riseRate":0,"avgChangeRate":-0.087601},{"month":4,"riseRate":0.833333,"avgChangeRate":0.021573},{"month":5,"riseRate":0.5,"avgChangeRate":0.035469},{"month":6,"riseRate":0.833333,"avgChangeRate":0.020567},{"month":7,"riseRate":0.8,"avgChangeRate":0.040575},{"month":8,"riseRate":0.6,"avgChangeRate":0.00833},{"month":9,"riseRate":0.4,"avgChangeRate":0.013102},{"month":10,"riseRate":0.6,"avgChangeRate":0.101456},{"month":11,"riseRate":0.8,"avgChangeRate":0.02515},{"month":12,"riseRate":0.8,"avgChangeRate":0.23185}],"exchange":"NASDAQ","name":"Roivant Sciences Ltd.","nameEN":"Roivant Sciences Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Roivant Sciences Ltd.(ROIV),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Roivant Sciences Ltd.(ROIV) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Roivant Sciences Ltd.,ROIV,Roivant Sciences Ltd.股票,Roivant Sciences Ltd.股票老虎,Roivant Sciences Ltd.股票老虎国际,Roivant Sciences Ltd.行情,Roivant Sciences Ltd.股票行情,Roivant Sciences Ltd.股价,Roivant Sciences Ltd.股市,Roivant Sciences Ltd.股票价格,Roivant Sciences Ltd.股票交易,Roivant Sciences Ltd.股票购买,Roivant Sciences Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Roivant Sciences Ltd.(ROIV),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Roivant Sciences Ltd.(ROIV) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}